Clinical Trials Directory

Trials / Conditions / Female Breast Cancer

Female Breast Cancer

28 registered clinical trials studyying Female Breast Cancer — 6 currently recruiting.

StatusTrialSponsorPhase
RecruitingCulturally Adapting an Intervention to Increase Genetic Testing in African American Cancer Survivors
NCT07436078
Barbara Ann Karmanos Cancer InstituteN/A
RecruitingMelatonin Supplementation and Exercise Program in Breast Cancer Women
NCT06696378
University of ValladolidN/A
Active Not RecruitingExercise Program on Pain, Physical Function, and Quality of Life in Breast Cancer Survivors
NCT06618690
Universidad de BurgosN/A
RecruitingIIT2023-09-Chung-UpfrontTAD: Upfront TAD/SNB in Patients With Breast Cancer With Nodal Metastases
NCT06092892
Alice ChungPhase 2
RecruitingA Study of a Comprehensive Prevention Program to Reduce Lymphedema After Axillary Lymph Node Dissection in Peo
NCT06144164
Memorial Sloan Kettering Cancer CenterPhase 3
WithdrawnA Study of 1 8F-FDHT PET/MRIScans in Women With Breast Cancer
NCT06145399
Memorial Sloan Kettering Cancer CenterEARLY_Phase 1
UnknownPulsed Electromagnetic Fields for Analgesia Post Mastectomy
NCT06331793
European Institute of OncologyN/A
UnknownEfficacy of Neoadjuvant Endocrine Therapy Compared to Chemotherapy in Breast Cancer Patients
NCT05755581
Sohag UniversityPhase 1
RecruitingPROOFS-Registry - Premenopausal Women With Breast Cancer Optimally Treated With OFS
NCT05792150
West German Study Group—
UnknownThis is a Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study Evaluating the Ef
NCT05439499
Ahon Pharmaceutical Co., Ltd.Phase 3
UnknownAn Intervention for Female Breast CANcer: Acceptance and Commitment Therapy (I-CAN-ACT) for Depression and Phy
NCT05374161
University of CyprusN/A
UnknownThis is a Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study Evaluating the Ef
NCT05438810
Ahon Pharmaceutical Co., Ltd.Phase 3
CompletedExercise, Gut Microbiome, and Breast Cancer: Increasing Reach to Underserved Populations
NCT05000502
University of Alabama at BirminghamN/A
UnknownTomosymthesis for Breast Mass Lesion Characterization
NCT04863833
Asmaa Abdelmonem Ahmed—
RecruitingUltra-hypofractionated Radiotherapy in Breast Cancer Patients
NCT05586256
University Of Perugia—
UnknownPrefeRences And ChemoTherapy In Breast Cancer patiEnts
NCT06332976
European Institute of Oncology—
UnknownYoga on QOL Physiological Distress&Fatigue, on Patients Affected by Breast Cancer in Adjuvant Radiotherapy
NCT04775290
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCSN/A
TerminatedAcupuncture for Joint Symptoms in Patients With Breast Cancer
NCT03836872
The Hong Kong Polytechnic UniversityN/A
UnknownFemale Sexual Dysfunction in Breast Cancer Patients
NCT03153631
Assiut University—
WithdrawnEffect of TIVA Propofol vs Sevoflurane Anaesthetic on Serum Biomarkers and on PBMCs in Breast Cancer Surgery
NCT03005860
Tata Memorial CentreN/A
UnknownSilent Breast Cancer A Study of the Disease Prevalence Held by Imaging Guided Biopsies in Autopsy Specimens
NCT02480933
Centro Hospitalar Lisboa OcidentalN/A
UnknownAdjuvant Endocrine Therapy for Estrogen Receptor-beta Positive Triple Negative Breast Cancer
NCT02089854
Peking Union Medical College HospitalPhase 4
UnknownPlace of Comprehensive Geriatric Assessment in Patients ≥ 75 Years Care, With Breast Cancer, After Screening W
NCT03059875
Poitiers University HospitalN/A
UnknownSide Effect Prevention Training (SEPT) for Nocebo Effects in Breast Cancer Patients
NCT01741883
Philipps University MarburgN/A
CompletedDose Dense TC + Pegfilgrastim Support for Breast Cancer
NCT01671319
University of Wisconsin, MadisonPhase 2
UnknownExpectations and Side Effects of Endocrine Therapy in Women With Breast Cancer
NCT02088710
Philipps University Marburg—
TerminatedEstrogen for Triple Negative Breast Cancer
NCT01083641
University of Wisconsin, MadisonPhase 2
SuspendedBreast Cancer in Young Women: Is it Different?
NCT01320488
National Guard Health Affairs—